中国小儿血液与肿瘤杂志
中國小兒血液與腫瘤雜誌
중국소인혈액여종류잡지
JOURNAL OF CHINA PEDIATRIC BLOOD AND CANCER
2014年
6期
298-302,307
,共6页
田鑫%贺湘玲%郑敏翠%伍艳鹏%邹润英%邹惠%游亚兰%刘华%朱秀娟
田鑫%賀湘玲%鄭敏翠%伍豔鵬%鄒潤英%鄒惠%遊亞蘭%劉華%硃秀娟
전흠%하상령%정민취%오염붕%추윤영%추혜%유아란%류화%주수연
亚甲基四氢叶酸还原酶%胸苷酸合成酶%基因多态性%甲氨蝶呤%毒副作用
亞甲基四氫葉痠還原酶%胸苷痠閤成酶%基因多態性%甲氨蝶呤%毒副作用
아갑기사경협산환원매%흉감산합성매%기인다태성%갑안접령%독부작용
ThymidylateSynthase%Geneticpolymorphisms%MTX%Toxicity
目的:探讨 MTHFR、TS基因多态性联合作用对ALL患儿HD-MTX化疗后不良反应的影响,以及与MTX血药浓度变化之间的关系;分析MTHFR、TS基因多态性联合作用在个体化治疗及疾病防治中的作用。方法 ALL患儿73例,提取其基因组DNA,PCR扩增后测序鉴定MTHFR C677T、MTHFR A1298C、TS 5’-UTR的基因型。观察所有ALL患儿HD-MTX化疗后的毒副作用,并监测MTX血药浓度。以Logistic 回归分析基因多态性与化疗毒副作用的危险度;采用Fisher精确概率法比较 HD-MTX 化疗后 MTHFR C677T、MTHFR A1298C、TS 的不同基因型之间42~48 h MTX血药浓度的差异,以P<0.05为差异有显著性。结果(1)MTHFR677 CT/TT合并1298 AC/CC基因型者,其血红蛋白降低发生的风险下降了2.9倍,而黏膜损害发生的风险则增加了4.3倍,但差异均无显著性。(2)MTHFR1298 AC/CC合并TS 3R/3R基因型者,其发生黏膜损害的风险增加了5.4倍,差异有显著性(χ2=4.911,P=0.027)。(3)MTHFR677 CT/TT合并TS 3 R/3R基因型与HD-MTX化疗毒副作用的发生无关。(4)MTHFR677 CT/TT+MTHFR1298 AC/CC+TS 3 R/3 R基因型者,其黏膜损害发生的风险增加了7.5倍,且差异有显著性(χ2=5.295,P =0.021)。结论 TS和MTHFRC677T基因多态性可与ALL患儿HD-MTX化疗后黏膜损害的发生有关。
目的:探討 MTHFR、TS基因多態性聯閤作用對ALL患兒HD-MTX化療後不良反應的影響,以及與MTX血藥濃度變化之間的關繫;分析MTHFR、TS基因多態性聯閤作用在箇體化治療及疾病防治中的作用。方法 ALL患兒73例,提取其基因組DNA,PCR擴增後測序鑒定MTHFR C677T、MTHFR A1298C、TS 5’-UTR的基因型。觀察所有ALL患兒HD-MTX化療後的毒副作用,併鑑測MTX血藥濃度。以Logistic 迴歸分析基因多態性與化療毒副作用的危險度;採用Fisher精確概率法比較 HD-MTX 化療後 MTHFR C677T、MTHFR A1298C、TS 的不同基因型之間42~48 h MTX血藥濃度的差異,以P<0.05為差異有顯著性。結果(1)MTHFR677 CT/TT閤併1298 AC/CC基因型者,其血紅蛋白降低髮生的風險下降瞭2.9倍,而黏膜損害髮生的風險則增加瞭4.3倍,但差異均無顯著性。(2)MTHFR1298 AC/CC閤併TS 3R/3R基因型者,其髮生黏膜損害的風險增加瞭5.4倍,差異有顯著性(χ2=4.911,P=0.027)。(3)MTHFR677 CT/TT閤併TS 3 R/3R基因型與HD-MTX化療毒副作用的髮生無關。(4)MTHFR677 CT/TT+MTHFR1298 AC/CC+TS 3 R/3 R基因型者,其黏膜損害髮生的風險增加瞭7.5倍,且差異有顯著性(χ2=5.295,P =0.021)。結論 TS和MTHFRC677T基因多態性可與ALL患兒HD-MTX化療後黏膜損害的髮生有關。
목적:탐토 MTHFR、TS기인다태성연합작용대ALL환인HD-MTX화료후불량반응적영향,이급여MTX혈약농도변화지간적관계;분석MTHFR、TS기인다태성연합작용재개체화치료급질병방치중적작용。방법 ALL환인73례,제취기기인조DNA,PCR확증후측서감정MTHFR C677T、MTHFR A1298C、TS 5’-UTR적기인형。관찰소유ALL환인HD-MTX화료후적독부작용,병감측MTX혈약농도。이Logistic 회귀분석기인다태성여화료독부작용적위험도;채용Fisher정학개솔법비교 HD-MTX 화료후 MTHFR C677T、MTHFR A1298C、TS 적불동기인형지간42~48 h MTX혈약농도적차이,이P<0.05위차이유현저성。결과(1)MTHFR677 CT/TT합병1298 AC/CC기인형자,기혈홍단백강저발생적풍험하강료2.9배,이점막손해발생적풍험칙증가료4.3배,단차이균무현저성。(2)MTHFR1298 AC/CC합병TS 3R/3R기인형자,기발생점막손해적풍험증가료5.4배,차이유현저성(χ2=4.911,P=0.027)。(3)MTHFR677 CT/TT합병TS 3 R/3R기인형여HD-MTX화료독부작용적발생무관。(4)MTHFR677 CT/TT+MTHFR1298 AC/CC+TS 3 R/3 R기인형자,기점막손해발생적풍험증가료7.5배,차차이유현저성(χ2=5.295,P =0.021)。결론 TS화MTHFRC677T기인다태성가여ALL환인HD-MTX화료후점막손해적발생유관。
Objective TodiscusstheinfluenceofMTHFRandTSgeneticpolymorphismswith MTX-related toxicity to acute lymphoblastic leukemia and the association with MTX plasma concentration;Analysis the role of MTHFR and TS genetic polymorphisms in individualized treatment and prevention of ALL.Methods Atotalof73childrenwithacutelymphoblasticleukemiawereselected,andDNAwas extracted from their peripheral blood.The genotypes of MTHFR and TS 5 ’-UTR were detected by direct DNA sequencing after PCR.The toxicity response of patients received HD- MTX chemotherapy was observed,and MTX plasma concentration was surveyed.SPSS 1 3.0 were applied for statistical analysis, the Logistic Regression analysis was applied to study the relationship between genetic polymorphisms and the risk of toxicities;the Fisher’s extended exact test was applied to study the association of MTHFR,TS genetic polymorphisms with 42-48 MTX plasma concentration,P<0.05 were accepted as statistically significant.Results (1 )Patients carrying MTHFR677 CT/TT and 1 298 AC/CC genotype had 2.9-fold higher incidence rate of anemia and 4.3-fold higher incidence rate of mucous membrane damage,but it had no significant difference.(2)The incidence rate of mucous membrane damage was 5.4-fold higher in carriers of MTHFR1 298 AC/CC genotype and TS 3R/3R genotype (OR=5.41 ,CI:1 .22 ~24.09). (3 )MTHFR677 CT/TT and TS 3 R/3 R genotypes had no significant association with the incidence rate of HD-MTX-related toxicities to ALL.(4)Patients carrying MTHFR677 CT/TT,1 298 AC/CC and TS 3R/3R genotype had 7.5-fold higher incidence rate of mucous membrane damage (OR=7.50,CI:1 .35 ~41.72).Conclusions TSandMTHFRC677Tgeneticpolymorphismscanincreasetheinfluenceofthe incidence rate of mucous membrane damage to ALL with MTHFR A1 298C.